Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Propranolol Combined With Intralesional Bleomycin for Infantile Hemangioma
NCT07104526Completed
- Sponsor
- Wuhan No.1 Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bleomycin in infantile hemangioma (IH) (2 arms), sponsored by Wuhan No.1 Hospital. Primary endpoint: Clinical Therapeutic Effect at 6 months. Started Jan 2024; status: completed.
02
Drugs
bleomycin
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT07104526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07104526.